Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Unknown 3Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 12Recurrence 9Neoplasms 8Leukemia, Myeloid, Acute 7Hematologic Neoplasms 7Colorectal Neoplasms 7Pancreatic Neoplasms 6Lymphoma, B-Cell 6Carcinoma, Hepatocellular 6Breast Neoplasms 6Sarcoma 5Prostatic Neoplasms 5Lymphoma 5Burkitt Lymphoma 5Neoplasms, Plasma Cell 4Myasthenia Gravis 4Lung Neoplasms 4Glioblastoma 4Brain Neoplasms 4Stomach Neoplasms 3Solid Tumor 3Pituitary Neoplasms 3Ovarian Neoplasms 3Melanoma 3Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Head and Neck Neoplasms 3Glioma 3Carcinoma, Non-Small-Cell Lung 3Advanced Solid Tumors 3

Interventions

alovudine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Not yet recruiting × Metastatic Castration-resistant Prostate Cancer × Clear all
NCT07609225 2026-05-27

Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy

University of Wisconsin, Madison

Phase EARLY_PHASE1 Not yet recruiting
15 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡